CTAS
46
-3
CCL
77
-5
CVX
32
-3
CSX
44
-13
CL
58
-12
BXP
46
-4
DAL
65
-3
AA
57
-7
CB
53
-2
AMP
75
-3
CME
48
2
CMA
73
-2
CAH
66
3
CMS
57
-3
ALL
41
-3
DD
60
-3
A
60
-2
CNP
52
2
BDX
65
20
AIZ
69
-2
CTAS
46
-3
CCL
77
-5
CVX
32
-3
CSX
44
-13
CL
58
-12
BXP
46
-4
DAL
65
-3
AA
57
-7
CB
53
-2
AMP
75
-3
CME
48
2
CMA
73
-2
CAH
66
3
CMS
57
-3
ALL
41
-3
DD
60
-3
A
60
-2
CNP
52
2
BDX
65
20
AIZ
69
-2
Financhill
Back

Merck KGaA 10K Form

Buy
58

MKKGY
Merck KGaA

Last Price:
$26.16
Seasonality Move:
2.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MKKGY News And Ratings

See the #1 stock for the next 7 days that we like better than MKKGY

MKKGY Financial Statistics

Sales & Book Value

Annual Sales: $22.9B
Cash Flow: $33.7M
Price / Cash Flow: 24.15
Annual Sales: $14.85
Price / Book: 1.76

Profitability

EPS (TTM): 1.39460
Net Income (TTM): $3B
Gross Margin: $13.5B
Return on Equity: 9.69%
Return on Assets: 5.61%

Merck KGaA Earnings Forecast

Key Merck KGaA Financial Ratios

  • The Gross Profit Margin over the past 23 years for MKKGY is 59.01%.
  • The Selling, General & Administrative Expenses for MKKGY have been equal to 25.34% of Gross Profit Margin.
  • The Research & Development expenses have been 10.77% of Revenue.
  • The Interest Expense is 10.51% of Operating Income.
  • The Net Earning history of MKKGY is 13.13% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 12 years.

Merck KGaA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: MKKGY
Website: emdgroup.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 1.31
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 18.85
Forward P/E Ratio: 12.1

MKKGY Technical Analysis vs Fundamental Analysis

Buy
58
Merck KGaA (MKKGY) is a Buy

Is Merck KGaA a Buy or a Sell?

  • Merck KGaA stock is rated a Buy
    The current Merck KGaA [MKKGY] share price is $26.08. The Score for MKKGY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.